Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Hormone and Metabolic Research , 1986
Rehabilitation increases metabolic demand
While efficacy endpoints for weight loss in those trials were modest, the compound exhibited a favorable safety profile, supporting its later GRAS designation for food use
Multiple assessments have found it to be non-irritating and non-sensitizing to most people
The individual peptides in the glow stack have favorable safety profiles in research, but long-term human data is limited
AEDG is a small hydrophilic tetrapeptide with negligible plasma-protein binding, no documented cytochrome-P450 (CYP) metabolism, and no described interaction with organic-anion or organic-cation transporter families
US$ 23.83
US$ 20.19
US$ 26.30
US$ 24.56
US$ 24.24
US$ 23.84
